☆ 4.7 Article

PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Pharmacology & Pharmacy

Antitumor activity and molecular mechanism of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition

Huimin Sun et al.

Summary: Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays an important role in regulating cholesterol metabolism and lipoprotein homeostasis. In addition to its role in cardiovascular diseases, PCSK9 has been found to be involved in tumor development and progression. Inhibition of PCSK9 can attenuate tumor progression and promote apoptosis of cancer cells.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Circulating follicular helper T cells and subsets are associated with immune response to hepatitis B vaccination

Mingjuan Yin et al.

Summary: This study investigates the immune response to hepatitis B vaccination and finds similar kinetics between circulating Tfh cells and splenic Tfh cells; cTfh cells are positively correlated with anti-HBs at one week after vaccination; in vitro experiments show preferential activation of CXCR3(-)Tfh cell subsets in peripheral blood mononuclear cells stimulated by HBsAg.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

添加到收藏夹

Review Medicine, Research & Experimental

EMT, cancer stem cells and autophagy; The three main axes of metastasis

Ghader Babaei et al.

Summary: Epithelial-mesenchymal transition (EMT) and Cancer stem-like cells (CSCs) are major factors contributing to cancer cell metastasis. Autophagy has recently gained attention, playing a dual role in cancer cell development depending on cancer type, tissue, and stage. Studies show different signaling pathways are involved in cancer stem cells, autophagy, and EMT. Investigating effective signaling pathways in all three processes could help determine appropriate therapeutic goals.

BIOMEDICINE & PHARMACOTHERAPY (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling

Junlong Zhao et al.

Summary: The study uncovered novel mechanisms of miR-144/miR-451a cluster deregulation and the interaction between malignant cells and tumor-associated macrophages (TAMs) in HCC. This provides new insights into HCC pathogenesis and diagnostic strategies.

MOLECULAR CANCER (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Proprotein convertase subtilisin/kexin type 9 (PCSK9): A potential multifaceted player in cancer

Anindita Bhattacharya et al.

Summary: PCSK9 has emerged as a novel pharmacological target for hypercholesterolemia and associated cardiovascular diseases, and its aberrant expression in a broad spectrum of cancers suggests its potential as a valuable biomarker and therapeutic target in personalized cancer medicine.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

添加到收藏夹

Article Medicine, Research & Experimental

PCSK9 and cancer: Rethinking the link

Khadijeh Mahboobnia et al.

Summary: PCSK9 plays an important role in the development and progression of various cancers, highlighting its potential significance in cancer treatment. Inhibiting PCSK9 may help suppress the proliferation and invasion of tumor cells. However, the current lack of data on the role of PCSK9 in cancer and the impact of PCSK9 inhibition in cancer therapy limits our understanding of its effectiveness and safety.

BIOMEDICINE & PHARMACOTHERAPY (2021)

添加到收藏夹

Article Oncology

Influence of cholesterol on cancer progression and therapy

Shyamananda Singh Mayengbam et al.

Summary: Cholesterol plays a crucial role in maintaining cell structure and normal biological function, but is also linked to lifestyle-related diseases. Research has shown alterations in blood cholesterol levels in cancer patients compared to healthy individuals, highlighting its significance in cancer progression and therapy.

TRANSLATIONAL ONCOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

The PCSK9 discovery, an inactive protease with varied functions in hypercholesterolemia, viral infections, and cancer

Nabil G. Seidah

Summary: PCSK9 is a significant protein in LDL-C metabolism, modulating cholesterol levels by influencing the degradation of LDLR. It also plays roles in regulating various processes such as atherosclerosis and immune modulation. Injectable PCSK9 monoclonal antibody is currently used in treating hypercholesterolemia.

JOURNAL OF LIPID RESEARCH (2021)

添加到收藏夹

Article Immunology

Pro-protein convertase subtilisin/kexin type 9 promotes intestinal tumor development by activating Janus kinase 2/signal transducer and activator of transcription 3/SOCS3 signaling in ApcMin/+ mice

Kai Yang et al.

Summary: The study demonstrated that PCSK9 may have a potential oncogenic role in the development and progression of colorectal cancer in vivo via activation of JAK2/STAT3/SOCS3 signaling pathway. Overexpression of PCSK9 led to increased adenomas and adenocarcinomas in mice, while treatment with evolocumab reduced tumor growth and prevented the development of adenocarcinomas.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2021)

添加到收藏夹

Review Immunology

Lactate modulation of immune responses in inflammatory versus tumour microenvironments

Michelangelo Certo et al.

Summary: The microenvironments of cancerous tissues and tissues affected by chronic inflammatory diseases exhibit different immune states but similar metabolic states. Understanding the metabolic signature allows for therapeutic intervention to reset metabolite availability and correct dysregulated immune states.

NATURE REVIEWS IMMUNOLOGY (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1

Zufeng Ding et al.

CARDIOVASCULAR RESEARCH (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression

Samir Devalaraja et al.

CELL (2020)

添加到收藏夹

Review Multidisciplinary Sciences

Metabolic reprogramming and cancer progression

Brandon Faubert et al.

SCIENCE (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Engineering Macrophages for Cancer Immunotherapy and Drug Delivery

Yuqiong Xia et al.

ADVANCED MATERIALS (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Pseurotin A as a novel suppressor of hormone dependent breast cancer progression and recurrence by inhibiting PCSK9 secretion and interaction with LDL receptor

Khaldoun S. Abdelwahed et al.

PHARMACOLOGICAL RESEARCH (2020)

添加到收藏夹

Article Oncology

Cholesterol metabolism in drug-resistant cancer (Review)

Aiwen Yan et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2020)

添加到收藏夹

Review Immunology

Colorectal Cancer Immunotherapy: Options and Strategies

Nor Adzimah Johdi et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Review Physiology

Coming Back to Physiology: Extra Hepatic Functions of Proprotein Convertase Subtilisin/Kexin Type 9

Klaus-Dieter Schlueter et al.

FRONTIERS IN PHYSIOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer

Xinjian Liu et al.

NATURE (2020)

添加到收藏夹

Review Oncology

The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism

Gerta Hoxhaj et al.

NATURE REVIEWS CANCER (2020)

添加到收藏夹

Review Urology & Nephrology

MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential

Justin C. Penticuff et al.

NATURE REVIEWS UROLOGY (2019)

添加到收藏夹

Article Oncology

GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition

Zhou Yang et al.

CANCER BIOLOGY & THERAPY (2019)

添加到收藏夹

Review Genetics & Heredity

The relation between PI3K/AKT signalling pathway and cancer

Saeed Noorolyai et al.

GENE (2019)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

PCSK9 and inflammation: a review of experimental and clinical evidence

Amir Abbas Momtazi-Borojeni et al.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2019)

添加到收藏夹

Review Oncology

Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer

Sorbarikor Piawah et al.

CANCER (2019)

添加到收藏夹

Review Medicine, General & Internal

Colorectal cancer

Evelien Dekker et al.

LANCET (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Metabolic regulation of gene expression by histone lactylation

Di Zhang et al.

NATURE (2019)

添加到收藏夹

Article Medicine, General & Internal

Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer

Amir Abbas Momtazi-Borojeni et al.

ARCHIVES OF MEDICAL SCIENCE (2019)

添加到收藏夹

Review Medical Laboratory Technology

Prognostic role of serum total cholesterol and high-density lipoprotein cholesterol in cancer survivors: A systematic review and meta-analysis

Pingting Zhou et al.

CLINICA CHIMICA ACTA (2018)

添加到收藏夹

Article Dentistry, Oral Surgery & Medicine

O-GlcNAcylation in oral squamous cell carcinoma

Tassaporn Kongkaew et al.

JOURNAL OF ORAL PATHOLOGY & MEDICINE (2018)

添加到收藏夹

Article Medicine, General & Internal

Oral squamous carcinoma cells promote macrophage polarization in an MIF-dependent manner

M. Barbosa de Souza Rizzo et al.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2018)

添加到收藏夹

Article Oncology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Oxysterols selectively promote short-term apoptosis in tumor cell lines

Debora Levy et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Membrane cholesterol access into a G-protein-coupled receptor

Ramon Guixa-Gonzalez et al.

NATURE COMMUNICATIONS (2017)

添加到收藏夹

Article Cell Biology

Cholesterol Enhances Colorectal Cancer Progression via ROS Elevation and MAPK Signaling Pathway Activation

Caihua Wang et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)

添加到收藏夹

Article Oncology

The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice

Claudia Lanterna et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)

添加到收藏夹

Review Oncology

The Role of Cholesterol in Cancer

Omer F. Kuzu et al.

CANCER RESEARCH (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Cellular Cholesterol Directly Activates Smoothened in Hedgehog Signaling

Pengxiang Huang et al.

CELL (2016)

添加到收藏夹

Article Oncology

CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer

Hanxiao Xu et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2016)

添加到收藏夹

Review Chemistry, Medicinal

Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities

Ciaran O'Reilly et al.

MEDICINAL RESEARCH REVIEWS (2016)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9)

Rainer Schulz et al.

BASIC RESEARCH IN CARDIOLOGY (2015)

添加到收藏夹

Review Medicine, Research & Experimental

Targeting lactate metabolism for cancer therapeutics

Joanne R. Doherty et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

添加到收藏夹

Article Immunology

Control of Tumor-Associated Macrophage Alternative Activation by Macrophage Migration Inhibitory Factor

Kavitha Yaddanapudi et al.

JOURNAL OF IMMUNOLOGY (2013)

添加到收藏夹

News Item Biotechnology & Applied Microbiology

Phase 3 data for PCSK9 inhibitor wows

Cormac Sheridan

NATURE BIOTECHNOLOGY (2013)

添加到收藏夹

Article Pharmacology & Pharmacy

Control of the immune system by oxysterols and cancer development

Catia Traversari et al.

CURRENT OPINION IN PHARMACOLOGY (2012)

添加到收藏夹

Article Developmental Biology

Epithelial-mesenchymal transitions: insights from development

Jormay Lim et al.

DEVELOPMENT (2012)

添加到收藏夹

Article Oncology

Proprotein Convertase Subtilisin/Kexin Type 9 Deficiency Reduces Melanoma Metastasis in Liver

Xiaowei Sun et al.

NEOPLASIA (2012)

添加到收藏夹

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

CELL (2011)

添加到收藏夹

Article Chemistry, Medicinal

The Lipogenesis Pathway as a Cancer Target

Hanley N. Abramson

JOURNAL OF MEDICINAL CHEMISTRY (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

PCSK9-deficient mice exhibit impaired glucose tolerance and pancreatic islet abnormalities

Majambu Mbikay et al.

FEBS LETTERS (2010)

添加到收藏夹

Article Cell Biology

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Affects Gene Expression Pathways Beyond Cholesterol Metabolism in Liver Cells

Hong Lan et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2010)

添加到收藏夹

Review Biochemistry & Molecular Biology

Epithelial-Mesenchymal Transitions in Development and Disease

Jean Paul Thiery et al.

CELL (2009)

添加到收藏夹

Article Cell Biology

Genome-wide expression analysis of cells expressing gain of function mutant D374Y-PCSK9

Trine Ranheim et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2008)

添加到收藏夹

Article Genetics & Heredity

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

M Abifadel et al.

NATURE GENETICS (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.